SPERM.ST STO
Spermosens AB
1W: +0.0%
1M: -6.7%
3M: -20.8%
YTD: +20.0%
1Y: +13.5%
3Y: -98.9%
5Y: -99.9%
kr 0.01 ($0.00)
-0.00 (-4.76%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Capkr 25.4M ($2.5M)
52W Range0.0042-0.012
Volume1,603,244
Avg Volume5,301,503
Beta0.13
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTore Duvold
Employees4
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2021-05-19
Websitespermosens.com
Medicon Village
Lund, SN 223 81
SE
Lund, SN 223 81
SE
46 7 63 11 40 91
About Spermosens AB
Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.
Latest News
No recent news
Recent Insider Trades
No insider trades found